Insider Transactions in Q4 2021 at Tricida, Inc. (TCDA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Gerrit Klaerner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,767
-0.75%
|
$24,903
$9.56 P/Share
|
|
Dec 31
2021
|
Geoffrey M. Parker COO, CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-2.13%
|
$12,456
$9.56 P/Share
|
|
Dec 31
2021
|
Dawn Parsell Otto EVP, Clinical Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,574
-31.24%
|
$14,166
$9.56 P/Share
|
|
Dec 31
2021
|
Wilhelm Stahl EVP, Chief Tech Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-6.0%
|
$12,456
$9.56 P/Share
|
|
Dec 31
2021
|
Robert Mc Kague EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-15.21%
|
$12,456
$9.56 P/Share
|
|
Dec 20
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
7,500
-7.04%
|
$60,000
$8.54 P/Share
|
|
Dec 16
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
931
-0.87%
|
$7,448
$8.38 P/Share
|
|
Dec 15
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
2,550
-2.32%
|
$20,400
$8.01 P/Share
|
|
Dec 14
2021
|
Wilhelm Stahl EVP, Chief Tech Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-2.44%
|
$4,032
$7.7 P/Share
|
|
Dec 14
2021
|
Wilhelm Stahl EVP, Chief Tech Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,664
+6.58%
|
-
|
|
Dec 08
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
8,000
-2.12%
|
$56,000
$7.84 P/Share
|
|
Dec 08
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
500
-0.45%
|
$4,000
$8.0 P/Share
|
|
Dec 07
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
15,722
-12.46%
|
$125,776
$8.03 P/Share
|
|
Dec 01
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
1,600
-1.25%
|
$12,800
$8.02 P/Share
|
|
Nov 18
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
800
-0.62%
|
$5,600
$7.72 P/Share
|
|
Nov 17
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
10,297
-7.41%
|
$72,079
$7.9 P/Share
|
|
Nov 15
2021
|
David P Bonita Director |
BUY
Grant, award, or other acquisition
|
Indirect |
666,667
+6.09%
|
$4,000,002
$6.0 P/Share
|
|
Nov 15
2021
|
Geoffrey M. Parker COO, CFO and EVP |
BUY
Grant, award, or other acquisition
|
Indirect |
166,667
+38.91%
|
$1,000,002
$6.0 P/Share
|
|
Nov 15
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
126,000
-25.08%
|
$756,000
$6.02 P/Share
|
|
Nov 15
2021
|
Orbimed Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
666,667
+6.09%
|
$4,000,002
$6.0 P/Share
|
|
Oct 06
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.47%
|
$20,000
$4.22 P/Share
|